Naloxone Hydrochloride
- Product NDC
- 84549-071
- 11-digit product format
- 845490071
- Labeler code
- 84549
- Product ID
- 84549-071_3a388817-cca6-540d-e063-6294a90a6b35
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naloxone Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- ProPharma Distribution
- Application
- ANDA207633
- Marketing category
- ANDA
- Marketing start
- 2017-08-08
- Substance
- NALOXONE HYDROCHLORIDE
- Active strength
- .4 mg/mL
- Pharmacologic classes
- Opioid Antagonist [EPC], Opioid Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207633-001 | NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207633-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A207633-001 | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE / INJECTION | AP | 2017-08-08 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207633-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207633-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207633-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207633-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207633-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207633-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207633-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207633-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207633-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207633-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207633-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207633-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207633-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A207633-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207633-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207633-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207633-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A207633-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A207633-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A207633-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207633-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A207633-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A207633-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A207633-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A207633-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A207633-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A207633-001 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207633-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A207633-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A207633-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207633-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A207633-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207633-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207633-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A207633-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A207633-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207633-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A207633-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A207633-001 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A207633-001 | AP | 1 | cb3db0bc1861… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Naloxone Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NALOXONE HYDROCHLORIDE | .4 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F850569PQR | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1659929 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3856ea66-29b8-8fc2-e063-6394a90ac33a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c955d208-c333-9bd7-be34-d7e12986d44e | Product name | 6 | 20250626 |
| e5f98bfa-66d5-4c3a-b22d-9543d3bee304 | Product name | 1 | 20250204 |
| caa6391e-3db3-c912-335f-61b5fc00aa12 | Product name | 9 | 20240110 |
| 65a3bc34-04ff-4cf1-aad9-c7d92a062f6d | Product name | 1 | 20231003 |
| e951cdf3-f269-4d97-a7d5-c1c3d7283a7d | Product name | 3 | 20230313 |
| ab841ac7-728a-4fc9-be0a-35b96cecbf39 | Product name | 4 | 20230306 |
| f327b80c-8fa2-404b-838a-df3eec141cf2 | Product name | 1 | 20221212 |
| d4aa2fcf-79c3-4b5f-a00e-1a8e26e00119 | Product name | 1 | 20220511 |
| b871fccd-1de6-4c7f-b9e5-045304641ee6 | Product name | 8 | 20220118 |
| 43b1efe2-1425-4b3e-b3a2-57d40f8478b9 | Product name | 1 | 20211026 |
| 4c23a34c-e8fc-424c-8fa0-ee064ba6eaef | Product name | 1 | 20170706 |
| 0b8c7273-1da3-495f-909a-7cf1e96d2361 | Product name | 1 | 20161212 |
| 3df867ed-9d48-45cf-bded-1394beaea0b1 | Product name | 3 | 20161206 |
| 8a245632-e24f-4ccc-b671-995d89c96ebc | Product name | 1 | 20141203 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84549-071-10 | Naloxone Hydrochloride | 1 mL in 1 VIAL | INJECTION, SOLUTION | 1 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | A-S Medication Solutions | 5906381c-81f4-4635-867a-e56e4d629692 | 2026-06-03 | Warnings, Adverse reactions | 207633 ANDA207633 |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Somerset Therapeutics, LLC | dfa48492-d83b-48cc-9ad1-bdc0c2ac9931 | 2026-05-05 | Warnings, Adverse reactions | 207633 ANDA207633 |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Sina Health Inc | 2879294f-9af9-459e-e063-6394a90a0820 | 2026-01-12 | Warnings, Adverse reactions | 207633 ANDA207633 |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | ProPharma Distribution | 3856ea66-29b8-8fc2-e063-6394a90ac33a | 2025-07-18 | Warnings, Adverse reactions | 207633 ANDA207633 84549-071 |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 9e53f169-4a6e-6102-e053-2995a90ab3dc | 2023-05-09 | Warnings, Adverse reactions | 207633 ANDA207633 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1659929 | naloxone HCl 0.4 MG in 1 ML Injection | PSN | 3856ea66-29b8-8fc2-e063-6394a90ac33a | 3 |
| 1659929 | 1 ML naloxone hydrochloride 0.4 MG/ML Injection | SCD | 3856ea66-29b8-8fc2-e063-6394a90ac33a | 3 |
| 1659929 | naloxone HCl 0.4 MG per 1 ML Injection | SY | 3856ea66-29b8-8fc2-e063-6394a90ac33a | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 84549-071-10 | 84549007110 | 1 mL in 1 VIAL (84549-071-10) | 1 ml | 2025-08-27 | No | No | Current |